Originally published In Press as doi:10.1074/jbc.M101685200 on May 1, 2001
J. Biol. Chem., Vol. 276, Issue 39, 36557-36565, September 28, 2001
Xenopus Rhodopsin Promoter
IDENTIFICATION OF IMMEDIATE UPSTREAM SEQUENCES NECESSARY FOR
HIGH LEVEL, ROD-SPECIFIC TRANSCRIPTION*
Shobana S.
Mani
§,
Suchitra
Batni
§¶,
Leigh
Whitaker
,
Shiming
Chen
,
Gustav
Engbretson**
, and
Barry
E.
Knox
**§§
From the
Departments of Biochemistry and Molecular
Biology and ** Ophthalmology, State University of New
York Upstate Medical University, Syracuse, New York 13210, the
Department of Ophthalmology, Washington University School of
Medicine, St. Louis, Missouri 63110, and the

Department of Bioengineering and
Neuroscience, Syracuse University,
Syracuse, New York 13244
Received for publication, February 22, 2001, and in revised form, April 19, 2001
 |
ABSTRACT |
To understand the mechanisms that control the
cell-specific visual pigment gene transcription, the
Xenopus rhodopsin 5' regulatory region has been
characterized in vivo using transient transfection of
Xenopus embryos and transgenesis. The principal control
sequences were located within
233/+41, a region with significant
conservation with mammalian rhodopsin genes. DNase footprinting
indicated seven distinct regions that contain potential
cis-acting elements. Sequences near the initiation site
(
45/+41, basal region) were essential, but not sufficient, for
rod-specific transcription. Two negative regulatory regions were found,
one between
233 to
202, with no apparent similarity to known
elements, and a second Ret-1-like CAAT (
136/
122) motif. Deletion of
either sequence led to a 2-3-fold increase in expression levels,
without a change in rod specificity. Sequences between
170 to
146,
which contain an E-box motif, were necessary for high level expression
in transgenic tadpoles but not in transient transfections. Sequences
between
84 and
58, which contained an NRE-like consensus were found
to be necessary for high level expression in both assays. Although
expression levels were modulated by various proximal sequences in the
rhodopsin promoter, none of the tested sequences were found to be
necessary for rod specificity. Promoter constructs with a consensus
BAT-1 sequence in conjunction with an NRE-like element upstream of the basal promoter directed low level green fluorescent protein expression in the central nervous system in transgenic tadpoles. These results suggest that rod cell-specific expression of rhodopsin is controlled by
redundant elements in the proximal promoter.
 |
INTRODUCTION |
Phototransduction occurs in the photoreceptor layer of the
vertebrate retina, which is composed of distinct cell types: rods and
cones (1). These cells express a number of specific proteins that
regulate the light-dependent currents mediating vision (2, 3). Among these cell-specific proteins are the visual pigments, which
combine with 11-cis-retinal to form the light-sensitive component of the transduction cascade. The visual pigments are a large
family of genes, which contain rod-specific rhodopsins and at least
four classes of cone-specific opsins (4). Rhodopsin, required for
nocturnal vision, is the most abundant opsin in many vertebrate retinae
by virtue of the size of the rod outer segments, abundance of the rod
cells, and the high level of transcription. As such, the regulation of
rhodopsin expression has been a focus for understanding mechanisms of
cell-specific gene expression in the retina (5).
Transcription initiation has been identified as the major control point
for rhodopsin gene expression (6, 7). A variety of studies using
different approaches have demonstrated that important transcriptional
control sequences lie within the 5' upstream regions of various
rhodopsin genes. Functional assays using transgenic mice have shown
that 2-4 kb1 of upstream
sequences from the mouse and bovine rhodopsin genes direct reporter
gene expression to the photoreceptor layer (8, 9), with sequences
proximal to the initiation site (
500 and
222) being sufficient for
retina-specific expression. The importance of the proximal sequences is
highlighted by the high degree of homology found in this region among
vertebrate rhodopsins (10). However, the immediate upstream sequences
from the mammalian opsins were not able to limit expression of the
reporter to rods as expected for rhodopsin (11, 12). Expression levels
are also regulated by a sequence termed rhodopsin enhancer region,
located ~2 kb upstream of the initiation site (13). The binding of
retina-specific nuclear factors to rhodopsin upstream sequences have
been localized in both proximal and distal upstream regions, suggesting
a role for these elements in regulating expression (5). However, a complete description of the cis-acting elements that control
transcription in rod photoreceptors is not yet available. Transcription
factors that potentially regulate gene expression have been identified in the mammalian retina and several have been shown to activate rhodopsin expression in heterologous systems, e.g. Nrl (14, 15), Crx (16), and Erx (17). The mechanisms by which the different
cis-acting elements in the rhodopsin upstream regions function, either independently or in concert, to produce
rod-specific expression are not known.
We have used Xenopus embryos for transient transfection
studies and transgenesis to investigate rod-specific transcription. Previously, we found that a 5.5-kb rhodopsin upstream fragment was
transcriptionally active, driving the expression of reporter both in
Xenopus embryo transfections (10) and in transgenic frogs
(18). In this paper, we map the rhodopsin promoter to an upstream
region spanning nucleotides
508 to +41, capable of directing reporter
expression to the abundant rod cells as detected by immunolocalization
and GFP expression in transgenic Xenopus rod cells.
Furthermore, we have used mutational analysis and DNase footprinting to
define the functional limits of the promoter to the proximal ~233
nucleotides and found multiple regulatory regions that contribute to
the transcriptional activity in rod photoreceptors.
 |
EXPERIMENTAL PROCEDURES |
DNA Constructs
Upstream Fragments--
The plasmids pXOP(
5500/+41)luc and
pXOP(+41/
5500)luc contain the 5.5-kb upstream sequences from the
Xenopus rhodopsin gene, XOP, in the forward and
reverse directions, respectively, in pGL2 vector (Promega, WI) and were
constructed as described previously (10). pXOP(
1300/+41)luc was
derived from pXOP(
5500/+41)luc by SacI digestion and
religation of the 6.9-kb vector-containing fragment. pXOP(
503/+41)luc
was derived from pXOP(
1300/+41)luc by digestion with PstI
and KpnI. The resulting ends were filled-in using Klenow DNA
polymerase and religated. pXOP(
503/+41)luc (5800) was generated by
cloning a 5.8-kb BamHI genomic fragment containing the
Xenopus rhodopsin exons and downstream sequences, into the BamHI site downstream of the luciferase gene in
pXOP(
503/+41)luc.
5' Deletions--
The deletion series was constructed using
exonuclease III and mung bean nuclease digestion (Stratagene). The
plasmid containing a deletion of the TATA box region,
pXOP(
503/
46)luc, was constructed by digestion of pXOP(
503/+41)
with HindIII and subsequent religation.
Basal Region Constructs--
The TATA box region was isolated as
a HindIII fragment from pXOP(
503/+41)luc and cloned into
pGL2 in both orientations, pXOP(
46/+41)luc and pXOP(+41/
46)luc, as
well as a dimer, pXOP(
46/+41)2luc. All deletion
constructs were sequenced using the dideoxy chain termination method to
confirm the sequence and orientation of inserts. For transgenic
experiments, pXOP(
508/+41)GFP was generated by subcloning a
PstI-BamHI fragment into pEGFP
(18).
Targeted Disruptions--
Targeted disruptions of conserved
regions in the Xenopus rhodopsin promoter (
503/+41) were
generated using a PCR-based approach using primers (Table I) with a
PstI overhang (19). To generate the
(
84/
58), the PCR
primer (Table I) contained a
HindIII overhang, permitting direct cloning of the product
into pXOP(
52/+41)luc. A second construct that disrupted
84 to
58
but maintained the spacing of the native promoter was made by cloning a
synthetic oligonucleotide (5'-CTTGTACGGAGCTCTACTGTGCA-3') into the
PstI site in the
(
84/
58) construct. PCR was performed
using Ultma DNA polymerase (PerkinElmer Life Sciences).
The 5' products were digested with KpnI-PstI, the
3' products were digested with PstI-BamHI, and
constructs were generated by three-part ligation of
KpnI-PstI product with the
PstI-BamHI product. These were cloned
directionally into the KpnI-BglII sites of pGL2
(Promega, WI). All mutant promoter constructs were verified by
sequencing. The
(
136/
122) contained a single base change (G to C
at
386) in addition to the intended replacement of the Ret-1 site by
PstI.
View this table:
[in this window]
[in a new window]
|
Table I
List of primer sequences used in generating targeted deletion and
artificial constructs
The gene-specific forward primers were used in PCR reaction with GL2 3'
primer (5'-CGGGATCCAAGCTT-ACCAACAGTACCGGAATGCC-3'). The gene-specific
reverse primers were used in conjunction with the GL2 5' primer
(5'-GGGGTACCTGTATCTTATGGTACTGTAACTGA-3').
|
|
GFP Constructs--
The XOP basal region (
52/+41) was cloned
as a HindIII-BamHI fragment into complementary
sites in pEGFP (
) (18) to generate EGFP-XOP basal. This plasmid was
digested with KpnI and HindIII and gel-purified.
Rhodopsin-targeted deletion luciferase constructs were digested with
KpnI/HindIII and cloned into the
KpnI-HindIII sites of pEGFP XOP basal to generate
rhodopsin-targeted deletion constructs in EGFP. The
(
52/
38)
KpnI-HindIII fragment was cloned directly into
EGFP digested with the same enzymes. The clones were verified by
restriction digestion and sequencing. Plasmid preparations were
performed using the Qiagen protocol (Chatsworth, CA).
Basal Element Replacement Constructs--
Wild type
Xenopus rhodopsin promoter luciferase construct (
503/+41)
was digested with HindIII to liberate the basal region (
52/+41). The 93-bp basal region was replaced by synthetic
oligonucleotides encoding Xenopus rhodopsin basal region
(
52/
37) and Xenopus cardiac actin (CAR) basal region
(
36/+36) or with the CMV promoter basal region (
36/+28) with
HindIII linkers on either end. All constructs were confirmed
by sequencing, and plasmid DNA preparations were performed using the
Qiagen protocol.
Cardiac Actin Luciferase Constructs--
The cardiac actin
promoter (
3270/+23; Ref. 20) was liberated as a
KpnI-HindIII fragment and cloned directionally
into KpnI-HindIII sites in pGL2 (Promega, WI).
The clones were verified by restriction analysis and sequencing of
junctions to confirm the orientations. Luciferase constructs containing
Xenopus cardiac actin TATA and +1 (pCARTATA) were generated
by removing the XOP (
503/
52) region from XOP-CAR using
HindIII and SmaI. The ends were filled in using Klenow and religated. This construct contains XOP (
52/
37 and the
cardiac actin basal region (
36/+36) driving the expression of luciferase.
Artificial Promoter Construct--
Artificial promoter was made
by design of synthetic oligonucleotides (IDT, Coralville, IA).
p(
96/+41)GFP contained wild type sequence of the rhodopsin proximal
promoter from
96 to +41. Oligonucleotides were designed with
overhanging KpnI and HindIII sites, ligated into
the same sites in the XOP basal construct, and confirmed by sequencing.
Embryo Transfections
Embryos were obtained by in vitro fertilization
using hormonally induced adult Xenopus females (Nasco),
dejellied (21), and grown at 18-24 °C to stages 26-28 (22) in
0.1-0.2× MMR (1× MMR = 0.1 M NaCl, 2 mM
KCl, 1 mM MgSO4, 2 mM
CaCl2, 5 mM HEPES, pH 7.8, and 2.5 µg/ml
gentamycin), at which time the vitelline membrane was removed.
Transfections were performed as described elsewhere (23). In early
experiments, Lipofectin (Life Technologies, Inc.) was used; in later
experiments,
N-[1-(2,3-dioleyloxy)propyl]-N,N,N-triethylammonium methylsulfate (Roche Molecular Biochemicals) were used during these
studies and the amount of DNA and the DNA:lipid ratio were 6-12 µg
and 1:3, respectively. DNA used for transfections were either purified
by twice banding in CsCl (24) or by the Qiagen protocol. At least
two different preparations were tested for each plasmid. Groupwise
comparisons of mean activities (RLU/head) generated in individual
transfection trials were performed using single-factor analysis of
variance (
= 0.05 for planned comparisons; Ref. 25).
Transfection of trunks and whole embryos were done as controls. For
luciferase assay, the heads (6-10) were homogenized and aliquots were
assayed (using a protocol supplied by Promega) to determine the
picograms of luciferase produced per well. The luciferase assay gave
50,000-100,000 relative light units/pg of purified luciferase
(Sigma)/30 s using the single-channel luminometer (Berthold). Protein
estimations were done using the Bradford reagent (Bio-Rad) and bovine
serum albumin standards, and ranged from 10 to 20 µg/head. Luciferase
activity is reported as the mean (including all trials, n
given in figure legend) ± S.E.
Transgenic Xenopus
DNA was digested with XhoI to linearize the plasmid
and purified after digestion (High Pure PCR Product Purification Kit, Roche Molecular Biochemicals), with final elution in water. Transgenic Xenopus embryos were produced using restriction
enzyme-mediated integration as described (23). Normal embryos were
selected and cultured in 0.1× MMR at 18-20 °C until approximately
stage 41 (3-4 days), at which point non-mosaic green fluorescence
above the weak background fluorescence from the yolk could be observed. Normal tadpoles were maintained in 0.1× MMR and used for analysis. GFP-positive transgenic tadpoles were fixed overnight in
phosphate-buffered 4% paraformaldehyde. Frozen sections (10-15 µm
thickness) were photographed under bright field and fluorescent
lighting conditions (18). Photographic slides were scanned and figures
produced using Photoshop (Adobe). The brightness and contrast of the
images in sections from the various
construct transgenic tadpoles
were adjusted in order to visualize the cell type expressing the GFP reporter. At least three or four independent transgenic lines for each
construct were sectioned and analyzed. The pattern and intensity of GFP
expression between the various lines for any one construct was consistent.
DNase I Footprinting
Nuclear proteins were extracted from adult Xenopus
retinae as described (26). Glutathione S-transferase-tagged
bovine Crx homeodomain and flanking regions (residues
37-107, GST-CrxHD) and a hexahistidine-tagged mouse
Nrl (residues 16-237, His-Nrl) were
overexpressed and purified from Escherichia coli as
described previously (16, 27). 32P-End-labeled DNA
fragments of the Xenopus rhodopsin proximal promoter
(
279/+40) was generated by PCR amplification, and footprinting reactions were carried out as described previously (16). Varying concentrations of purified transcription factors (as indicated in Fig.
2 legend) were used in the footprinting reactions. 1 µg of
poly(dI-dC) was included only in the reactions containing retinal extracts.
 |
RESULTS |
Vertebrate Rhodopsin Upstream Sequence Comparisons--
Vertebrate
rhodopsin 5'-flanking regions possess significant interspecies
homology, with many short stretches of sequence identity in the 250-bp
region immediately upstream of the TATA box/initiation site (Fig.
1). The overall sequence identity in this
region ranged from 45% to 55% over a 200-bp stretch of sequence between Xenopus rhodopsin and other vertebrate rhodopsin
sequences, suggesting a potential role for these conserved sequences in
rhodopsin gene regulation. Several of the conserved regions in
XOP are similar to binding sites for transcription factors
in mammalian promoters: Ret4-like (
53/
38), which is a
binding site for Crx (16, 28); NRE-like
(
121/
110 and
84/
58), which is a binding site for a retina
specific leucine zipper protein, Nrl (15, 29); the GATTA
repeat (
106/
91), which is a binding site for Crx (16) and potentially Rx1; the photoreceptor cell element
PCE I/Ret1 (
133/
127), found in many
retina-specific genes, which is present immediately upstream of the
GATTA sequence in rhodopsin genes (30, 31); and the Ret2/E
box region (
158/
188) (13, 32). Such high proximal promoter
sequence homology highlights a potential conservation of the mechanism
regulating rhodopsin gene expression in vertebrate photoreceptors.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 1.
Sequence similarity in rhodopsin proximal
promoter region. Sequence alignments were generated using the
algorithm of Needleman and Wunsch (PILEUP program, version 9, GCG) and
displayed using Pretty Box, majority rules. The positions of XOP 4, XOP
3/E-box/Ret2, Ret I/PCE I, BAT1, NRE, and Ret 4 are indicated
below the aligned sequences. The TATA box region and the
transcriptional start site (+1) in the Xenopus rhodopsin
sequence are underlined. Arrowheads denote the
positions of the 5' deletion series, and the shaded boxes
represent the sequences targeted for disruption. Sequences used in the
comparison include Xenopus (XEN), chicken
(CHK), human (HUM), bovine (BOV), rat
(RAT), and mouse (MUS).
|
|
DNase Footprinting--
In order to locate binding sites for
potential transcription factors, DNase footprinting was performed on
the rhodopsin proximal promoter. Using an adult Xenopus
retinal extract, numerous extended regions were protected from
digestion, including those predicted from sequence comparisons in the
proximal promoter (Fig. 2A). At present, no Xenopus homologues of Crx, Nrl, or other
rod-specific transcription factors have been identified. Therefore,
footprinting of the proximal promoter was done using recombinant
mammalian proteins purified from E. coli: the bovine Crx
homeodomain (GST-CrxHD; Ref. 16) and the DNA binding domain and
surrounding bZIP regions of murine Nrl containing a hexahistidine tag
(His-Nrl; Ref. 27). Both proteins protected the rhodopsin proximal
region (Fig. 2, B and C). GST-CrxHD produced an
extended footprint encompassing the Crx consensus sites from
153/
73
on the sense strand and
70/
156 on the antisense strand,
respectively. Nrl protected a number of regions (
81/
56 on the sense
strand and
57/
84 on the antisense strand) that included an AP1
consensus region and NRE, adjacent to two Crx sites. These results
strongly suggest that the sequences in the Xenopus rhodopsin
proximal promoter contain binding sites for members of the Otx2-related
and neural retinal leucine zipper families.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 2.
DNase I footprint analysis of the
Xenopus rhodopsin proximal promoter ( 270/+40).
A, Xenopus retinal nuclear extract.
( ) indicates a reaction in which no protein was added. The reactions
were performed with 10, 5, 2.5, and 1 µg of protein on the sense (+)
and antisense ( ) strands in the presence of 1 µg of poly
d(I)·d(C). B, DNase footprinting analysis using purified
GST-CrxHD. Both sense (+) and antisense ( ) strand of the proximal
promoter were footprinted in the absence ( ) or presence of 100, 10, 1, and 0.1 ng of purified protein. C, DNase footprinting
using purified His tagged mNrl. Both the sense (+) and antisense ( )
strands were footprinted in the absence ( ) or presence of 140, 1.4, and 0.14 ng of purified protein. The lines and positions
relative to the transcriptional start site on the left
indicate the major protected areas and the corresponding sites in the
XOP proximal promoter are indicated on the right. Nucleotide
positions were determined by comparing to a sequencing ladder run
adjacent to the DNase-treated samples (data not shown).
|
|
Xenopus Rhodopsin Proximal Promoter: Analysis by Transfection of
Xenopus Embryos--
A comparison of promoter activity was performed
using an improved transfection protocol (23), which allows direct
comparison between the mean activities observed for different DNA
constructs, without normalization with a second reporter plasmid.
Initial experiments were performed using three upstream fragments:
(
5500/+41,
1300/+41, and
508/+41), which were all capable of
driving tissue-specific expression in embryos (Table
II). Comparative transfections performed at equimolar concentrations showed that the activity from the
5500/+41 fragment was ~35% lower compared with the other two promoters, which did not differ, although this difference was not
significant at p < 0.05. Size of the plasmid used in
the transfection appeared to have little influence on reporter gene
expression, as two derivatives containing additional sequences produced
similar results (Table II). One of the derivatives contained the
Xenopus rhodopsin gene and 3' sequences, suggesting no
significant transcriptional control regions downstream of the
initiation region. Unlike that observed in heads, reporter expression
from the upstream sequences in trunks was <2-fold over that obtained
using GL2, which produced a relatively consistent but very low level of
activity compared with heads transfected without DNA. We conclude that
the major regulatory elements are located in the 508-bp proximal
region.
To further characterize the transcriptional control sequences in the
proximal promoter, transgenic tadpoles were generated (18, 33) using
XOP(
508/+41) driving expression of GFP. GFP expression was found only
in the eye and, transiently, in the pineal. In fixed sections of
transgenic retina, GFP expression was observed only in rods (see
below). Each rhodopsin-positive cell also expressed GFP, with
expression apparent by stage 40 (data not shown). The levels of GFP
expression for the three large upstream constructs were qualitatively
very similar, confirming the results from the transfections: that there
is apparently no significant difference between these constructs. Taken
together, these results demonstrate that the immediate upstream
rhodopsin sequences direct expression to the rod cells.
Mapping the Rhodopsin Proximal Promoter--
To identify
cis-acting elements in the XOP proximal promoter, a series
of mutations in pXOP(
503/+41)luc were generated by either selective
removal of nucleotides or by sequential DNA deletions from the 5' end
(Fig. 3). The 92-bp encompassing the
transcription initiation site and including the TATA region were
essential for activity, as deletion of this region from the 503-bp
upstream fragment decreased luciferase expression 190-fold (Fig. 3).
Activity from the
503/
46 fragment was equivalent to the
promoterless control. However, the 92-bp region (
46/+41) in either
orientation or as a tandem repeat gave background levels of expression,
indicating that these nucleotides, although necessary, were not
sufficient for transcription of reporter plasmids.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of transcriptional activities from
5' deletions of the Xenopus rhodopsin promoter.
Activity (RLU/embryo) from the wild type construct, 503/+41
(n = 27), various deletion constructs
(n = 5-7), and GL2 (n = 8) is
presented as mean ± S.E. Data were analyzed for statistical
significance using single-factor analysis of variance ( = 0.05). Asterisks (*) indicate activities significantly
different from that of the 503/+41 fragment at p < 0.01. Double asterisks (**) indicate luciferase
levels similar to promoterless control (GL2) at p < 0.01.
|
|
Analysis of luciferase activity from 5' promoter deletions identified
other sequences required for promoter function. All of the deletion
constructs, except XOP(
44/+41), yielded luciferase activity
significantly above that obtained using GL2, in transfections of embryo
heads (Fig. 3). No significant differences in luciferase activity were
observed when nucleotides
508 to
234 were deleted (Fig. 3),
indicating that these nucleotides do not contribute significantly to
the head-specific transcription from the
503/+41 rhodopsin promoter
region. Deletion of the region spanning position
233 to
203
enhanced luciferase activity 2.4-2.8-fold over that observed using any
of the four larger constructs (Fig. 3). No significant changes in
activity compared with
202/+41 were obtained when nucleotides
202
to
171 were deleted. A drop in activity was observed with the
deletion of
170 to
145, with activity comparable to that obtained
using the full fragment,
508/+41. Thus, these results are consistent
with a second regulatory region from
170 to
146. A further decrease
in luciferase activity (4.5-fold) compared with XOP(
145/+41) was
found when
145 to
128 was deleted. A 40-fold stimulation of
luciferase expression from the
127/+41 fragment relative to that
obtained using XOP (
44/+41) indicated that the sequence spanning
positions
127 to
46 is the smallest fragment sufficient for
promoter activity.
To test for tissue specificity, embryonic trunks were transfected using
the various deletion constructs and activity was compared with the
corresponding activity in head by normalization to total protein. When
compared with the activity measured in heads, all trunk activities
except that of XOP(
127/+41) were less than 4% of the head activity.
Trunk activity from all the deletion constructs was slightly elevated
compared with
503/+41 and were also higher than GL2, suggesting that
some nonspecific, low level transcription may occur when nucleotides
503 to
330 are deleted. However, these results show predominant
head-specific expression driven by sequences further upstream of
proximal promoter sequences.
To further characterize the Xenopus rhodopsin proximal
promoter, targeted disruptions were created to replace putative
regulatory elements with a short linker sequence (Table I). To test if
the selective disruption resulted in expression in non-retinal cells, the mutant constructs were simultaneously analyzed by measuring reporter activity in transfected heads and trunks. A disruption of the
region from
233 to
203 of the Xenopus rhodopsin upstream sequence (XOP 4) resulted in a 3-fold increase in reporter gene expression in heads (Fig. 4). This
increase in activity in heads did not result in any significant change
in reporter activity measured in transfected trunks. These observations
are consistent with the increase in activity associated with the 5'
deletion construct lacking the
233/
203 region. The removal of
170
to
146 (XOP 3) did not alter the expression levels in transfected heads or trunks (Fig. 4). Selective disruption of the
Ret1-like core region and flanking nucleotides (
136 to
122) resulted in a 2-3-fold increase in luciferase expression in
heads as compared with the wild type promoter. This increase in
expression was not accompanied by any significant change in the levels
of reporter expression in trunks. Alteration of one of the NRE/AP1-like
sites (
120 to
109) did not significantly affect the head-specific expression of the rhodopsin promoter or lead to any change in activity
in trunks. However, disruption of the second NRE-like site (
84 to
58) dramatically reduced expression (Fig. 4). This was not caused by
a change in spacing since an additional construct in which the spacing
of the wild type rhodopsin promoter was maintained by addition of a
short insert of random sequence was also significantly lower than the
503/+41 promoter construct. These results indicate an essential role
for this NRE-like element in maintenance of high level expression of
rhodopsin in Xenopus rod cells. A change in either one (
98
to
91) or both (
107/
91) of the GATTA sequences caused a small
reduction in expression of the transgene, 20% or 32%, respectively,
that was not statistically significant. Finally, replacement of
nucleotides
52 to
38, corresponding to the conserved Ret4 region in the bovine rhodopsin upstream sequence, did
not change either the reporter luciferase levels or head-specific expression from the wild type promoter.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Transient transfections of Xenopus
embryos with rhodopsin targeted disruption constructs.
A, the proximal promoter region of Xenopus
rhodopsin ( 503/+41) showing the cis-acting sequences
targeted for disruption with the corresponding nucleotide positions are
shown. The nucleotides indicated in parentheses of each
1 construct was replaced with a PstI (CTGCAG)
sequence. The 84/ 58 sequence in 2 was replaced with
TGCA or with a random sequence that maintained the spacing
( 3). B, the luciferase activity from embryos
transfected with the various targeted disruption constructs are shown
relative to the activity observed by transfection of wild type XOP
( 503/+41) (n = 8). Asterisks (*) indicates
activities significantly different from that of the 503/+41 fragment
at p < 0.01. Double asterisks
(**) indicate luciferase levels similar to promoterless control at
p < 0.01.
|
|
Role of the Xenopus Rhodopsin Basal Element--
To address the
contribution of the basal region in determining the specificity of
expression from the Xenopus rhodopsin promoter, the
sequences encoding the TATA region, initiation site, and surrounding nucleotides were tested. The XOP basal region comprising nucleotides
36/+41 was replaced by basal element regions from two
non-retina-specific promoters, Xenopus cardiac actin
(
36/+36; Ref. 20) and CMV (
36/+25) promoters (Fig.
5A). These basal regions do
not possess any obvious sequence homology to the XOP basal region (Fig.
5B). Replacement of the XOP basal element with either
cardiac actin or CMV basal region did not significantly affect the
expression levels of the hybrid constructs as compared with wild type
rhodopsin in transfected heads or trunks (Fig. 5C). These
results show that the heterologous basal regions can functionally
substitute for the XOP basal region and that the upstream
cis-acting sequences are capable of controlling the cell
specificity of rhodopsin expression.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Transient transfections of Xenopus
embryos with XOP basal element replacement constructs.
A, the basal region of the Xenopus rhodopsin
proximal promoter ( 36/+41) was replaced with either the corresponding
basal region from Xenopus cardiac actin (XOP-CAR,
36/+36) or the CMV basal sequence (XOP-CMV, 36/+25).
B, sequence comparison of the Xenopus rhodopsin,
cardiac actin, and CMV promoter basal sequences show no discernible
homology in the sequences replaced. The dark
shaded boxes indicate the TATA region and the
transcriptional start site. The sequences in the gray
shaded box include the conserved Ret 4-core
sequence that was included while synthesizing the XOP-CAR and XOP-CMV
constructs. C, luciferase activity normalized to the wild
type promoter (WT) from four to six independent transfection
experiments using heads or trunks was plotted. Activity levels from the
wild type cardiac actin construct and CAR and CMV promoter in heads and
trunks are shown for comparison.
|
|
Transgenic Xenopus--
To investigate the cellular expression
patterns from the altered rhodopsin promoters, transgenic
Xenopus were generated with the various deletion constructs
driving expression of GFP. Several transgenic lines were generated for
each construct, and GFP expression was analyzed in tadpoles. Transgenic
animals harboring deletions of (
233/
203) and (
136/
122)
exhibited significant enhancement of GFP fluorescence, which was
restricted to the eye. Animals transgenic for XOP promoter deletion of
(
52/
38) showed GFP expression predominantly restricted to the
eye, with weak fluorescence in pineal and anterior head structures in a
few animals. The intensity of fluorescence in the eye was comparable to
that of transgenic tadpoles generated with the wild type (
508/+41)
rhodopsin construct. Deletion of
170 to
146 produced animals that
exhibited much lower levels of GFP expression, which was localized to
the eye. Transgenics with deletions of (
120/
109), (
98/
91) or
(
107/
91) had essentially wild type expression levels. Deletions of
the second NRE-like site (
84/
58) resulted in animals with extremely reduced levels of fluorescence in the eye, with expression fading to
undetectable in some animals. However, the expression from these four
constructs was strictly limited to the eye. To identify the cell type
expressing the reporter, transverse sections of retina were analyzed by
bright field and fluorescence microscopy. Within the eye, the
expression of GFP from all the targeted deletion constructs was
confined to the rod photoreceptor cells in the retina irrespective of
the differences in fluorescence levels (Fig.
6). These experiments show that the
mutant rhodopsin promoters are capable of directing rod-specific
expression in vivo. This extends and confirms the observed
head specificity of reporter expression in the transfection approach
using the various constructs and demonstrates a redundancy in
regulatory element function in targeting the expression of rhodopsin to
the rod photoreceptors.

View larger version (136K):
[in this window]
[in a new window]
|
Fig. 6.
Rod-specific expression of GFP reporter in
transgenic Xenopus generated with different targeted
disruption constructs. Bright field images of cross sections of
representative transgenic tadpoles generated using wild type
( 503/+41) or targeted disruption constructs showing the pigment
epithelium (PE) and different cellular layers
(photoreceptors (PR), inner nuclear layer (INL)
in the retina. The lens (L) and optic nerve (ON)
are seen only in a few sections. Fluorescence image of the same
sections show GFP expression limited to rods. Wild type section
magnification, ×20; mutant magnification, ×40. In order to identify
the cell type expressing GFP photographs were taken with varying
exposure times, as a result fluorescence intensities do not represent
actual levels of expression seen in individual tadpoles.
|
|
Artificial Promoter Constructs--
To test the role of the GATTA
and NRE-like element in targeting expression to rods, an artificial
promoter construct containing the
96/+41 region upstream of GFP was
used to generate transgenic animals. (Fig.
7). GFP expression was seen in the eyes
as well as the brain and portions of the spinal cord extending from the base of the brain to varying distances along the tail. Later in development, GFP expression became more cranially restricted and eventually faded to undetectable levels. These results suggest that the
GATTA region and the NRE-like element can support reporter gene
expression in the central nervous system during the early stages of
development. However, high level rod-specific expression requires the
presence of other sequences in the Xenopus rhodopsin proximal promoter.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
The BAT 1 and NRE sequences in an artificial
XOP promoter construct drives GFP expression in the developing central
nervous system. A, schematic representation of an
artificial promoter construct containing wild type XOP promoter
sequences from 96 to +41 driving expression of the GFP reporter gene.
The construct includes the 3' GATTAATA sequence of the BAT1 region
( 96/ 89), the NRE consensus sequence TG(N)8GC
( 73/ 62) denoted by boxes, and the basal promoter region
( 61/+41). The sequences upstream of 96 include a short (6 bp)
random linker used for cloning. B, developmental time course
of GFP expression in transgenic tadpoles generated using the 96/+41
GFP construct. Transgenic tadpoles were produced and analyzed for GFP
expression from 3 to 7 days post injection (dpi). Bright field and
fluorescent images of tadpoles generated with 96/+41GFP
(top panel) showing GFP expression in eye, brain,
and spinal cord 4-7 days after injection. The background auto
fluorescence from the yolk is seen in developing tadpoles injected with
either 96/+41 XOP-GFP or sperm nuclei alone (nontransgenic controls,
lower panels).
|
|
 |
DISCUSSION |
To study the mechanisms of rod-specific transcription in the
vertebrate retina, we have focused on the analysis of the
Xenopus rhodopsin promoter. Using a dual approach of embryo
transfections and transgenesis, in vivo functional
characterization of a rod-specific promoter has been performed in
photoreceptors. This environment is permissive for photoreceptor
cell-specific transcription, even though during transfection partial
disruption of cell contacts prevents normal rod outer segment formation
(34). The transfected heads are harvested at the onset of rhodopsin
expression and photoreceptors express endogenous rhodopsin to levels
similar to untreated heads at the same
stage.2 The levels of
luciferase with the complete promoter (
503/+41) are >100-fold higher
than the promoterless control, and direct comparison between various
constructs allowed us to quantitate the effects of removing individual
cis-acting elements. Transgenic approaches in
Xenopus have proven to be a powerful complementary approach
for the analysis of cell-specific promoters (18, 33), permitting the
in vivo analysis of transcription in chromatin (35, 36). In
the restriction enzyme-mediated integration method, multiple copies of
the plasmid integrate into random loci in the genome (18, 33). To
control for potential variation due to copy number and sites of
integration, independent transgenic lines were studied. Variation due
to the site of integration and/or cosuppression of supernumerary copies
of exogenous transgenes prevented direct comparison of expression
between individual animals (37, 38). Qualitative comparison of relative
expression levels for all animals made with the targeted deletion and
intact GFP reporter constructs in transgenic experiments was comparable
to the quantitative results found in transfection experiments with the
luciferase reporter constructs, except in the case of
XOP 3 (see
below). The pattern and temporal onset of transgene expression in
native photoreceptors was reproducible among animals generated with the
same construct. Therefore, transgenic animals permitted a clear
morphological identification of cell-specific expression, in a retina
with roughly equal numbers of rods and cones (39). The combined
approaches of transient transfection and transgenic analysis permitted
a detailed examination of cis-acting elements in the
Xenopus opsin promoter.
We have found four cis-acting regulatory elements in the
Xenopus rhodopsin proximal promoter, two of which function
as positive regulatory elements and two as negative regulatory
elements. The sequences between
84 and
58, which contain a match to
the binding site TG(N6-8)GC(A/C/T) for Nrl (class V
binding site; Ref. 27), are required for high level transcription in
both transgenic animals and transfected retina. Our data suggest that
these nucleotides contain an Nrl-like binding site, which in mammalian
promoters is located in the same position relative to the
transcriptional start site (15).
The Xenopus rhodopsin promoter contains a number of
potential Otx2-like binding sites (TAAT or ATTA) between
154 to
72. A GATTA repeat, previously identified as BAT-1, shows a high degree of
conservation among the opsin promoters (40) as well as other photoreceptor-specific genes (41). The BAT1 region in the bovine opsin
promoter has been shown to be a binding site for HMG I(Y) (29, 42) and
to contribute to the promoter activities in transfected cells, but not
in in vitro transcription assays (28). Surprisingly, targeted disruption of this region in the Xenopus promoter
caused no significant change in either transcriptional levels or
pattern of expression (Figs. 4 and 6). Moreover, the presence of a
GATTA sequence upstream of the basal promoter was not sufficient to support a high level of rod-specific expression in transgenic Xenopus (Fig. 7). The GATTA repeat may serve different
functions in the different photoreceptor gene promoters. In the case of the IRBP promoter, which drives expression in both rods and cones, deletion of the GATTA element dramatically reduced transcription in
transfected chick retinal cultures (43) and transgenic mice (44). In
this case, the Ret-1 GAATTA site was not sufficient to overcome the
mutations in the GATTA sequence. Due to the high degree of sequence
conservation across species, it is tempting to propose that the GATTA
region in XOP does have a functional role. Our inability to detect a
significant effect in the BAT-1 mutation experiments (Figs. 4 and 6)
could be explained by the presence of redundant elements in the
proximal promoter.
Targeted disruption of the conserved cis-acting element,
Ret-1/PCE I in the Xenopus opsin promoter resulted in a
2-fold increase in transcriptional activity in transfected retina and
increased GFP expression in transgenic animals. The discrepancy between the results obtained in the 5' deletion and targeted disruptions indicates that the regulatory properties of the Ret-1 element may be
determined by upstream cis-acting sequences, perhaps through interactions with transcription factors bound to these elements. This
supports our results obtained using synthetic promoter constructs, containing one or more copies of the Ret-1 region (
144 to
120) upstream of the rhodopsin basal region (
51/+41), which contribute to
0.1% or less of the Xenopus rhodopsin promoter's
transcriptional activity in transient transfections (data not shown).
Several proteins have been shown to bind to the Ret-1/PCE I sequence
including Crx (16), Rx (31), and Erx (17), each of which functions as a
weak transcriptional activator in transfection assays. However, these
proteins most likely interact with other retinal transcription factors,
as seen in the case of a direct interaction between Nrl and Crx (16,
45), resulting in synergistic activation of the bovine opsin promoter.
It is unclear if the spacing of the Ret-1 sequence relative to the
transcriptional start site affects its regulatory role. The targeted
disruptions may have resulted in a promoter conformation more favorable
to the assembly of transcription factors, thereby stimulating the
transcriptional activity.
The region between
170 to
146 (XOP 3) and
233 and
203 (XOP 4)
contains sequences that were footprinted with adult Xenopus nuclear extracts (Fig. 2A). In retinal transfections,
deletion of
233 to
203 caused a 3-fold increase in transcription
that was also seen in transgenic animals, suggesting that this region contains a negative regulatory element. The sequences in the XOP 4 region do not possess any sequence similarity to the mammalian opsin
promoters or a recognizable consensus transcription factor binding
site. Although there is evidence for a negative regulatory region in
mammalian opsin promoters, the sequences do not share any similarity
with XOP 4. There is limited sequence similarity between the
Xenopus and mammalian promoters in the XOP 3, only encompassing an E-box motif, CANNTG at nucleotide
163 to
158. In
the mouse opsin promoter, the equivalent E-box sequences were shown to
bind MASH-1 using mobility shift assays (46). The Xenopus homologues of MASH proteins (XASH-1 and XASH-3) are only expressed in
the ciliary margins in the laminated retina (47) and not in the
photoreceptors. Therefore, if XOP 3 function is regulated by its
conserved E-box motif, then either a different class of bHLH proteins
bind to this region in the Xenopus opsin promoter, or the
effect of XOP 3 on opsin expression is exerted at a step prior to
photoreceptor differentiation. Targeted disruption of these sequences,
however, showed no change in transfected retina but greatly reduced
levels of reporter expression in transgenic animals. The discrepancy
between the two assays for this construct suggests that protein binding
to XOP 3 deletion may be sensitive to the chromatin environment or the
proteins that bind to XOP 3 may be part of the chromatin-remodeling
complex. This region contains an AT-rich sequences (at least five
consecutive A/T at
152 to
147). Further experiments are needed to
determine if HMG I(Y) actually binds to the Xenopus proximal
promoter and activates transcription via any of these sequences.
 |
ACKNOWLEDGEMENTS |
We thank S. Moody and M. Pierce for helpful
suggestions, C. Schlueter and M. Ji for assistance in making some of
the transgenic Xenopus, T. Kerppola for providing the
purified mNrl protein, and R. Barlow for support and encouragement
during these studies.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants EY09409, EY11256, and EY12975 (all to B. E. K.),
National Institutes of Health Grant EY00667 (to R. B.), and a
grant from the Research to Prevent Blindness Foundation and the Lion's
Club of Central New York.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
Present address: CLONTECH Laboratories,
Palo Alto, CA, 94303-4230.
§§
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, SUNY Upstate Medical University, 750. E. Adams
St., Syracuse, NY 13210. Tel.: 315-464-8719; Fax: 315-464-8750;
E-mail: knoxb@mail.upstate.edu.
Published, JBC Papers in Press, May 1, 2001, DOI 10.1074/jbc.M101685200
2
S. S. Mani, S. Batni, L. Whitaker, S. Chen,
G. Engbretson, and B. E. Knox, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
kb, kilobase pair(s);
bp, base pair(s);
XOP, Xenopus rhodopsin gene;
RLU, relative light unit(s);
luc, luciferase;
GFP, green fluorescent
protein;
Nrl, neural retinal leucine zipper transcription factor;
Crx, Cone-rod homeobox transcription factor, Erx, Empty spiracles-related
homeobox, Rx, Pax6-related homeobox;
CMV, cytomegalovirus;
PCR, polymerase chain reaction;
EGFP, enhanced green fluorescent protein;
CAR, cardiac actin.
 |
REFERENCES |
| 1.
|
Dowling, J. E.
(1987)
The Retina: An Approachable Part of the Brain
, pp. 12-41, Harvard University Press, Cambridge, MA
|
| 2.
|
Hargrave, P. A.,
and McDowell, J. H.
(1992)
FASEB J.
6,
2323-2331
|
| 3.
|
Yarfitz, S.,
and Hurley, J. B.
(1994)
J. Biol. Chem.
269,
14329-14332
|
| 4.
|
Yokoyama, S.
(1996)
Genes Cells
1,
787-794
|
| 5.
|
Kumar, R.,
and Zack, D. J.
(1995)
in
Molecular Genetics of Ocular Diseases
(Wiggs, J. L., ed)
, pp. 139-160, Wiley-Liss, Inc., New York
|
| 6.
|
Treisman, J. E.,
Morabito, M. A.,
and Barnstable, C. J.
(1988)
Mol. Cell. Biol.
8,
1570-1579
|
| 7.
|
DesJardin, L. E.,
Timmers, A. M.,
and Hauswirth, W. W.
(1993)
J. Biol. Chem.
268,
6953-6960
|
| 8.
|
Lem, J.,
Applebury, M. L.,
Falk, J. D.,
Flannery, J. G.,
and Simon, M. I.
(1991)
Neuron
6,
201-210
|
| 9.
|
Zack, D. J.,
Bennett, J.,
Wang, Y.,
Davenport, C.,
Klaunberg, B.,
Gearhart, J.,
and Nathans, J.
(1991)
Neuron
6,
187-199
|
| 10.
|
Batni, S.,
Scalzetti, L.,
Moody, S. A.,
and Knox, B. E.
(1996)
J. Biol. Chem.
271,
3179-3186
|
| 11.
|
Gouras, P.,
Kjeldbye, H.,
and Zack, D. J.
(1994)
Visual Neurosci.
11,
1227-1231
|
| 12.
|
Woodford, B. J.,
Chen, J.,
and Simon, M. I.
(1994)
Exp. Eye Res.
58,
631-635
|
| 13.
|
Nie, Z.,
Chen, S.,
Kumar, R.,
and Zack, D. J.
(1996)
J. Biol. Chem.
271,
2667-2675
|
| 14.
|
Swaroop, A.,
Xu, J. Z.,
Pawar, H.,
Jackson, A.,
Skolnick, C.,
and Agarwal, N.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
266-270
|
| 15.
|
Rehemtulla, A.,
Warwar, R.,
Kumar, R.,
Ji, X.,
Zack, D. J.,
and Swaroop, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
191-5
|
| 16.
|
Chen, S.,
Wang, Q. L.,
Nie, Z.,
Sun, H.,
Lennon, G.,
Copeland, N. G.,
Gilbert, D. J.,
Jenkins, N. A.,
and Zack, D. J.
(1997)
Neuron
19,
1017-1030
|
| 17.
|
Martinez, J. A.,
and Barnstable, C. J.
(1998)
Biochem. Biophys. Res. Commun.
250,
175-180
|
| 18.
|
Knox, B. E.,
Schlueter, C.,
Sanger, B. M.,
Green, C. B.,
and Besharse, J. C.
(1998)
FEBS Lett.
423,
117-121
|
| 19.
|
Tomic-Canic, M.,
Sunjevaric, I.,
and Blumenberg, M.
(1996)
Meth. Mol. Biol.
57,
259-267
|
| 20.
|
Mohun, T. J.,
Taylor, M. V.,
Garrett, N.,
and Gurdon, J. B.
(1989)
EMBO J.
8,
1153-1161
|
| 21.
|
Newport, J. W.,
and Kirschner, M. W.
(1984)
Cell
37,
731-742
|
| 22.
|
Nieuwkoop, P.,
and Faber, P.
(1967)
Normal Table of Xenopus laevis
, pp. 162-189, North Holland Publishing, Amsterdam
|
| 23.
|
Batni, S.,
Mani, S. S.,
Schlueter, C.,
Ji, M.,
and Knox, B. E.
(2000)
Methods Enzymol.
316,
50-64
|
| 24.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1992)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 25.
|
Sokal, R. R.,
and Rohlf, F. J.
(1995)
Biometry
, 3rd Ed.
, pp. 229-260, W. H. Freeman and Co., New York
|
| 26.
|
Andrews, N. C.,
and Faller, D. V.
(1991)
Nucleic Acids Res.
19,
2499
|
| 27.
|
Kerppola, T. K.,
and Curran, T.
(1994)
Oncogene
9,
675-684
|
| 28.
|
Chen, S.,
and Zack, D. J.
(1996)
J. Biol. Chem.
271,
28549-28557
|
| 29.
|
Kumar, R.,
Chen, S.,
Scheurer, D.,
Wang, Q. L.,
Duh, E.,
Sung, C. H.,
Rehemtulla, A.,
Swaroop, A.,
Adler, R.,
and Zack, D. J.
(1996)
J. Biol. Chem.
271,
29612-29618
|
| 30.
|
Kikuchi, T.,
Raju, K.,
Breitman, M. L.,
and Shinohara, T.
(1993)
Mol. Cell. Biol.
13,
4400-4408
|
| 31.
|
Kimura, A.,
Singh, D.,
Wawrousek, E. F.,
Kikuchi, M.,
Nakamura, M.,
and Shinohara, T.
(2000)
J. Biol. Chem.
275,
1152-1160
|
| 32.
|
Yu, X.,
Chung, M.,
Morabito, M. A.,
and Barnstable, C. J.
(1993)
Biochem. Biophys. Res. Commun.
191,
76-82
|
| 33.
|
Kroll, K. L.,
and Amaya, E.
(1996)
Development
122,
3173-3183
|
| 34.
|
Stiemke, M. M.,
Landers, R. A.,
al-Ubaidi, M. R.,
Rayborn, M. E.,
and Hollyfield, J. G.
(1994)
Dev. Biol.
162,
169-180
|
| 35.
|
Wolffe, A. P.
(1994)
Cell
77,
13-16
|
| 36.
|
Struhl, K.
(1996)
Cell
84,
179-182
|
| 37.
|
Pal-Bhadra, M.,
Bhadra, U.,
and Birchler, J. A.
(1997)
Cell
90,
479-490
|
| 38.
|
Bingham, P. M.
(1997)
Cell
90,
385-387
|
| 39.
|
Saxen, L.
(1954)
Ann. Acad. Sci. Fenn. A
23,
1-95
|
| 40.
|
DesJardin, L. E.,
and Hauswirth, W. W.
(1996)
Invest. Ophthalmol. Vis. Sci.
37,
154-165
|
| 41.
|
Bobola, N.,
Briata, P.,
Ilengo, C.,
Rosatto, N.,
Craft, C.,
Corte, G.,
and Ravazzolo, R.
(1999)
Mech. Dev.
82,
165-169
|
| 42.
|
Chau, K. Y.,
Munshi, N.,
Keane-Myers, A.,
Cheung-Chau, K. W.,
Tai, A. K.,
Manfioletti, G.,
Dorey, C. K.,
Thanos, D.,
Zack, D. J.,
and Ono, S. J.
(2000)
J. Neurosci.
20,
7317-7324
|
| 43.
|
Boatright, J. H.,
Buono, R.,
Bruno, J.,
Lang, R. K.,
Si, J. S.,
Shinohara, T.,
Peoples, J. W.,
and Nickerson, J. M.
(1997)
Exp. Eye Res.
64,
269-277
|
| 44.
|
Bobola, N.,
Hirsch, E.,
Albini, A.,
Altruda, F.,
Noonan, D.,
and Ravazzolo, R.
(1995)
J. Biol. Chem.
270,
1289-1294
|
| 45.
|
Mitton, K. P.,
Swain, P. K.,
Chen, S.,
Xu, S.,
Zack, D. J.,
and Swaroop, A.
(2000)
J. Biol. Chem.
275,
29794-29799
|
| 46.
|
Ahmad, I.
(1995)
Brain Res. Dev. Brain Res.
90,
184-189
|
| 47.
|
Perron, M.,
and Harris, W.
(1999)
in
Cell Lineage and Fate Determination
(Moody, S., ed)
, pp. 353-365, Academic Press, San Diego, CA
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This